Stay updated with breaking news from Pipeline Update. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and...
06.11.2023 - Positive clinical data updates across multiple drug classes including antibody-drug conjugate (ADC) candidates BNT323/DB-1303, BNT325/DB-1305, CAR-T candidate BNT211, T cell therapy candidate BNT221 and mRNA cancer vaccine candidate BNT116Progress ...
COVID-19 vaccine franchise focused on vaccine adaptation readiness ahead of the fall season and advancing next generation vaccine candidates and combinationsBioNTech and partner OncoC4 plan to start a
Initiated patient enrollment in a U.S. Phase 2/3 study of CTX-009 in patients with advanced biliary tract cancers . Top line data is expected in the first half of 2024Continue to enroll in a U.S.... | May 4, 2023
Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update New York & London & Paris, April 28, 2023 - Aptorum Group Limited , a... | April 28, 2023